Show
Sort by
-
HDAC6 : one protein, two domains, diverse therapeutic opportunities : inhibitor synthesis and validation in cellular disease models
(2023) -
- Journal Article
- A1
- open access
The zinc-binding group effect : lessons from non-hydroxamic acid vorinostat analogs
-
The ubiquitin binding domain of HDAC6 : a key regulator of aggresomal protein disposal and new therapeutic target to combat multiple myeloma
-
The notorious Z.B.G. : synthesis and biological evaluation of potent HDAC6 selective inhibitors with a non-hydroxamic acid zinc-binding group to overcome therapeutic limitations
-
The principal pivot : new potent HDAC6 selective inhibitors with a non-hydroxamic acid zinc binding group for applications beyond oncology
-
- Conference Paper
- C3
- open access
The ubiquitin binding domain of HDAC6 : a key regulator of aggresomal protein disposal and new therapeutic target to combat multiple myeloma
-
- Journal Article
- A1
- open access
Carboxylic acid bioisosteres in medicinal chemistry : synthesis and properties
-
- Journal Article
- A1
- open access
Identification of mercaptoacetamide-based HDAC6 inhibitors via a lean inhibitor strategy : screening, synthesis, and biological evaluation
-
- Journal Article
- A1
- open access
Synthesis of indoline‐based benzhydroxamic acids as potential HDAC6 inhibitors
-
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models